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Abstract
Cardiac output (CO) is a cardinal parameter of cardiovascular state, and a fundamental
determinant of global oxygen delivery. Historically, measurement of CO has been limited
to critically-ill patients, using invasive indicator-dilution methods such as thermodilution
via Swan-Ganz lines, which carry risks. Over the past century, the premise that CO could
be estimated by analysis of the arterial blood pressure (ABP) waveform has captured the
attention of many investigators. This approach of estimating CO is minimally invasive,
cheap, and can be done continuously as long as ABP waveforms are available. Over a dozen
different methods of estimating CO from ABP waveforms have been proposed and some
are commercialized. However, the effectiveness of this approach is nebular. Performance
validation studies in the past have mostly been conducted on a small set of subjects under
well-controlled laboratory conditions. It is entirely possible that there will be circumstances
in real world clinical practice in which CO estimation produces inaccurate results.
In this thesis, our goals are to (1) build a computational system that estimates CO
using 11 of the established methods; (2) evaluate and compare the performance of the CO
estimation methods on a large set clinical data, using the simultaneously available ther-
modilution CO measurements as gold-standard; and (3) design and evaluate an algorithm
that identifies and eliminates ABP waveform segments of poor quality.
Out of the 11 CO estimation methods studied, there is one method (Liljestrand method)
that is clearly more accurate than the rest. Across our study population of 120 subjects, the
Liljestrand method has an error distribution with a 1 standard deviation error of 0.8 L/min,
which is roughly twice that of thermodilution CO. These results suggest that although CO
estimation methods may not generate the most precise values, they are still useful for
detecting significant (>1 L/min) changes in CO.
Thesis Supervisor: Roger G. Mark
Title: Distinguished Professor in Health Sciences and Technology
Professor of Electrical Engineering
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Chapter 1
Introduction
1.1 Motivation
The cardiovascular system provides vital nutrients and removes wastes from body tissues.
The powerhouse of the cardiovascular system is the heart, pumping out oxygenated blood
to the systemic circulation (Figure 1-1). For a normal healthy adult at rest, cardiac output
(CO), the average flow rate of blood pumped into the aorta, is approximately 5 liters
per minute. For an Olympic athlete at maximum workout, CO exceeds 30 L/min. For
a patient in circulatory shock, CO can be less than 2 L/min. The tremendous dynamic
range suggests that CO is a key indicator of one's hemodynamic state. Thus, it would be
a tremendous asset to determine CO accurately, reliably, and continuously using minimally
invasive methods.
1.1.1 Measurement of cardiac output
Flowmeter. The most direct and accurate way of measuring CO is to use a flowmeter. One
could conceivably place an ultrasonic flow probe around a major vessel protruding from the
heart such as the aorta. Instantaneous pulsatile flow is obtained with a millisecond time
resolution. Stroke volume, the volume of blood ejected into the aorta per cardiac cycle,
is calculated by integrating the flow curve over a cardiac cycle. CO is then obtained by
multiplying stroke volume with heart rate. Unfortunately, this direct flow measurement
requires thoracotomy (surgical incision of the chest wall), which is impractical to perform
in humans just for diagnostic purposes.
Fick principle. A more practical way to obtain CO is through the Fick principle of
02 mass balance. It states that the amount of 02 consumed must equal the difference in
02 quantity between the arterial and venous circulation. Using this fact, CO is obtained as
follows:
CO a02 consumption [L 0 2 /min]
arterial 02 content - mixed venous 02 content [L 0 2 /L blood]
Therefore, to determine CO, 02 consumption and content in blood need to be measured.
Thermodilution. Another clinically plausible method of obtaining CO is through an
indicator dilution technique, which is based upon conservation of the indicator solution.
As shown in Figure 1-2, cardiac output Q flows entirely through a large vessel. A known
amount of dye is injected at point A, and concentration as a function of time is measured
13
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Figure 1-1: The cardiovascular system. Figure adapted from [13].
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downstream at point B. By dye conservation, the amount injected must pass through point
B, and CO is obtained as follows:
CO = [mg]
f t2 c(t)dt [mg-min/(L blood)]
Clinically, the most popular indicator dilution technique is thermodilution, in which cold
saline of precisely known volume and temperature is injected, and then the temperature
profile is measured downstream.
Mixer
QA
q mg c~eLcunp, Phokmcell
inje*d WD Densitmeter
t2
Time
Figure 1-2: Indicator dilution principle. Figure adapted from [2].
Doppler ultrasound. More recently, a completely noninvasive method known as
doppler ultrasound has been developed to measure CO [8]. This technique measures the
aorta's instantaneous blood flow velocity v(t) and cross sectional area A. Then stroke
volume can be calculated by integrating v(t) over a cardiac cycle of duration T:
SV = Aj v(t)dt
Remarks. Although the Fick method and thermodilution are both clinically feasible,
they are still quite invasive and can only be performed in well-equipped environments like
intensive care units (ICUs) and cardiac catheterization labs. Measurement of mixed venous
02 requires a blood sample from the pulmonary artery. Injection of cold saline must be into
a major vessel through which the entire CO flows. Consequently, a Swan-Ganz catheter
that is threaded through the vena cava, through the right heart, and into the pulmonary
artery is used to facilitate thermodilution CO measurements. Doppler ultrasound, while
completely noninvasive and reasonably accurate, is expensive. Running this device requires
costly equipment and an expert technician. In addition, none of the methods discussed in
this section are practical for continuous bedside monitoring of a patient's CO.
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1.1.2 Estimating cardiac output from arterial blood pressure
Throughout the past century, the premise that CO could be estimated by analysis of the
arterial blood pressure (ABP) waveform (Figure 1-3) has captured the attention of many
investigators. More than a dozen methods of calculating CO from ABP have been proposed,
many of which are now commercially available. This approach to determine CO has the
following advantages:
" Obtaining ABP is non-invasive or minimally invasive.
" ABP waveforms are routinely measured in clinical settings such as ICUs.
" The ABP waveform is measured continuously, allowing for continuous CO estimates.
" Cost benefits: The transformation from ABP to CO requires only numerical compu-
tation. No expensive equipment or expert technicians are required.
O100 --
80 --
60 --
40 -
0 0.5 1 1.5 2 2.5 3
time [sec]
Figure 1-3: The arterial blood pressure (ABP) waveform.
To understand the relation between pressure (ABP) and flow (CO), we first start with
a very simple representation of the cardiovascular system. Shown in Figure 1-4, there are
two blocks: the heart and the systemic circulation. Blood flows out of the heart with a
rate of q(t) and a corresponding arterial pressure P(t). Assuming that the internal state of
the heart and the systemic circulation does not change, then it is plausible that higher flow
corresponds to higher pressure. Unfortunately, in real life, system states such as systemic
resistance can dynamically change within seconds, giving rise to a much more complicated
pressure-flow relationship. The dozen or so methods of determining flow from pressure
use cardiovascular system models and represent the internal structure of the two blocks in
Figure 1-4 with varying levels of complexity, thereby quantitatively relating P(t) and q(t).
Having so many different P - q relations existing today suggests that there is no con-
sensus as to which method works best. Studies conducted in the past have mostly been on
animals or a small set of human subjects under well-controlled laboratory conditions. The
CO estimators have not been extensively evaluated with a large set of clinical ABP wave-
forms, hence the performance of CO estimation is still uncertain. It is entirely possible that
there will be circumstances in real world clinical practice in which these indirect methods
produce unacceptable estimates. The main goal of the research presented in this thesis is
to determine the performance of the CO estimators.
1.1.3 MIMIC II database & data quality
Before evaluating the performance of CO estimation, we must first establish a suitable
study population that contains ABP waveform data and contemporaneous reference CO
16
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Figure 1-4: A simple, lumped cardiovascular system. The heart nourishes the systemic
circulation with blood at flow rate q(t) with arterial pressure P(t).
measurements (along with other pertinent clinical details such as patient age, presence or
absence of valve disease, etc.). The Multi-parameter Intelligent Monitoring for Intensive
Care II (MIMIC II) database [16] is the product of an initiative by the MIT Laboratory
for Computational Physiology (LCP) to create a massive, temporal database to facilitate
the research and development of an Advanced Patient Monitoring System. Currently, this
database has physiologic waveform data from over 3500 ICU patients hospitalized at Beth
Israel Deaconess Medical Center, Boston, USA.
Prom this database, we identified 120 patients with simultaneously available ABP wave-
forms (125-Hz sampled) and thermodilution CO measurements. Since MIMIC II data is
collected in a far less controlled environment than a typical research laboratory setting, ABP
waveforms are prone to corruption, causing CO estimators to generate bizarre outputs. To
address this problem, an algorithm that identifies and rejects bad waveform segments is
required.
1.2 Thesis goals
The research presented in this thesis aims to achieve the following:
" To study the principles of CO estimation from ABP waveforms and build a compu-
tational system that estimates CO using 11 of the established methods.
" To evaluate and compare the performance of the CO estimation methods on a large set
clinical data from the MIMIC II database and determine whether the CO estimation
is useful for clinical use.
" To design and evaluate an algorithm that quantifies ABP waveform quality.
1.3 Thesis outline
This thesis is divided into six chapters and two appendices.
Chapter 2, Cardiac Output Estimation Theory, explains the principles of the 11 different
methods we study for CO estimation. Physiologic principles and theory from electrical
17
circuits are used whenever appropriate to provide intuition. Limitations of CO estimation
are also discussed.
Chapter 3, Signal Abnormality Indexing, addresses the key issue of ABP waveform
quality. CO estimation relies on a clean ABP waveform, in which pressure and temporal
features may be reliably obtained. This chapter discusses the design and evaluation of an
algorithm that flags poor quality ABP waveforms.
Chapter 4, Evaluation Methods, explains the computational system built to evaluate CO
estimation, which involves database extraction, ABP waveform processing, CO estimator
implementation, and performance evaluation.
Chapter 5, Results and Discussion, reports the performance of CO estimation. We
discuss subset error analysis to determine the physiologic situations in which CO estimators
are likely to be more erroneous.
Chapter 6, Conclusions and Future Research, summarizes the important findings from
this research and suggests possible areas worthy of further exploration.
Appendix A presents a table summarizing the acronyms and mathematical notations
used throughout this thesis. Appendix B contains input/output relations of important
MATLAB source code to help elucidate Chapter 4.
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Chapter 2
Cardiac Output Estimation Theory
In the cardiovascular system, the relationship between arterial blood pressure (ABP) and
cardiac output (CO) is quite complex. Over a dozen methods of estimating flow from pres-
sure have been proposed. Most of the methods operate at a beat-by-beat time resolution,
calculating the stroke volume of each beat. Then, CO is calculated by multiplying stroke
volume with heart rate. The bases of these methods are models of the systemic circulation.
Table 2.1 lists the 11 CO estimators studied in this thesis. (Several CO estimators are
not studied because (1) the algorithms described in publications were unclear or (2) they
are too similar to one of the 11 estimators in Table 2.1.) All expressions given in the table
are proportional to CO. The proportionality constant encapsulates terms such as arterial
compliance and peripheral resistance that are not obtainable from a given model. The first
5 methods are based on lumped-parameter circuit models of circulation. The next 4 are
based upon distributed transmission line models. The last 2 are lumped circuit models with
ability to produce instantaneous flow waveforms, which becomes CO when time-averaged.
Table 2.1: Cardiac output estimators
CO estimator
Mean arterial pressure
Windkessel [5]
Windkessel RC decay [4]
Herd [7]
Liljestrand nonlinear compliance [12]
CO = k - below
Pm
PP -f
Pm - In -T Pd
(Pm Pd) f
P.. - f
Systolic area [19] As. f
Systolic area with correction [19, 10] (1+ A)  f
Systolic area with corrected impedance [21] (163 + f - 0.48 -Pm) -As f
Pressure root-mean-square-simplified form of [9] ((P(t) - Pm) 2 ) f
Godje nonlinear compliance [6] complex formula
Wesseling Modelflow [20] nonlinear, time-varying model
See Appendix A for notational explanations.
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2.1 Lumped parameter methods
2.1.1 Mean arterial pressure
In the simplest model, the heart is represented as a current source and systemic circulation
as a resistor (Figure 2-1). This circuit analogy is only appropriate for time-averaged flow, not
pulsatile flow. Given mean arterial pressure and systemic resistance, CO may be computed
via Ohm's law as follows:
PmQ =R
+
Q {R Pm
Figure 2-1: Mean arterial pressure Pm and cardiac output Q.
2.1.2 Windkessel model [5]
The arteries are capable of storing blood. Even with zero transmural pressure across the
arterial walls, approximately 500ml of blood can reside inside the arterial system for a
nominal person. At a mean arterial pressure of 100mmHg, 700ml of blood are in the
arteries [13]. Therefore, it is sensible to represent the arteries as a capacitor (Figure 2-2).
This model is the Windkessel model.
q(t) P(t)
q(t) R C P(t)
LL t LTdt
Figure 2-2: The Windkessel RC circuit model. The heart is modeled as a flow source q(t)
with impulse train ejections. Systemic circulation is modeled with arteriolar resistance R
and arterial compliance C. The ABP waveform P(t) generated has an infinitesimally short
systolic duration followed by exponential decay during diastole.
One major "upgrade" in the Windkessel model is in its ability to capture the pulsatility
of the cardiovascular system. The current source, now as an ideal pulsatile pump, generates
a periodic impulse train, which gives rise to the ABP waveform P(t). From circuit theory,
it can be shown that in steady state, stroke volume is proportional to the amplitude of the
ABP waveform (P, - Pd) and arterial capacitance. Thus, CO is given as:
Q = C.-P -f
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2.1.3 Windkessel RC decay [4]
If the time constant r of the Windkessel RC circuit model is known, then cardiac output
may be computed in another way:
Pm Pm PmQ=P-=C-P =C-PR RC T
There are several methods to determine -r:
* Use the Windkessel idealization that ejection is instantaneous. This way, the entire
cardiac cycle is in exponential decay from systolic to diastolic pressure. Mathemati-
cally,
Pd = Pe-Tl
where T is the beat period. Solving for r, we obtain:
T
In 
Pd
Hence, the final CO expression:
PM PsQ = C - T - In -P-T Pd
" Perform a least squares fit of an exponential decay to the diastole portion of the ABP
waveform. Then, the best-fitted r is obtained.
" Use a refined exponential fitting technique by Mukkamula et al. [14].
In this thesis, r is obtained separately using the first two methods.
2.1.4 Herd [7]
The Herd method proposes that stroke volume is proportional to Pm-Pd. This methodology
is based upon empirical evidence and no physiologic intuition is given [7].
2.1.5 Liljestrand nonlinear compliance [12]
Arterial capacitance is not constant but varies as a function of pressure. As arterial pressure
increases, arterial walls stiffen, reducing capacitance. From the Windkessel model point of
view, the Liljestrand and Zander method takes into account the nonlinearity using C =
kSP (Figure 2-3). Hence, CO becomes:
kQ = - P-fPs + Pd
2.2 Pressure-area methods
One major problem with lumped parameter models is that the arterial tree is really a
distributed, not lumped system (Figure 2-4). In theory, the arterial tree could be more
21
q(t) R C P(t)
Figure 2-3: Windkessel model with nonlinear capacitor. Liljestrand and Zander propose
that C oc (P + P)-'.
accurately modeled using the transmission line circuitry, which captures the distributed
nature and associated effects such as impedance and wave reflections. Although none of
the pressure-area methods are explicitly derived from transmission line circuit theory, the
arterial tree is approached from a distributed system point of view.
2.2.1 Systolic area [19]
One key observation made from the distributed arterial tree is that stroke volume is pro-
portional to the area under the systole region (A,) of the ABP waveform (Figure 2-6). CO
becomes:
Q = k - A, - f
2.2.2 Systolic area with correction [19, 10]
First appearing in Warner et al. [19], a (1 + T/T) correction factor was applied to the
previous CO estimation method. This factor is probably compensating for the fact that
the duration of systole, T, is not a negligible fraction of the beat period, thereby causing
outflow from the capacitor to the resistor. The exact physiologic rationale is unexplained.
CO estimate with this correction factor becomes:
Q= k - 1+ T As. f
Td
2.2.3 Systolic area with corrected impedance [21]
Wesseling et al. [21] introduced another correction factor based upon empirical evidence
and optimal regression analysis. With the corrected impedance factor, CO becomes:
Q = k. (163+ f - 0.48 - Pm) - As f
2.2.4 Pressure root-mean-square [9]
An adaption of LiDCO's CO method [9], stroke volume is thought to be proportional to the
root-mean-square of each cycle in the ABP waveform. From AC circuit theory, root-mean-
square of an AC voltage waveform is proportional to power. Thus, this method believes
that stroke volume and AC power of the ABP waveform are linearly related. Thus, CO
becomes:
Q = k -r((P(t) - Pm) -f = k -o-(P(t)) - f
Note that root-mean-square and standard deviation a- are numerically equivalent.
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Figure 2-4: Arterial tree of a dog. In reality, the arterial tree is more accurately modeled
by transmission lines rather than lumped parameter model. Figure adapted from [15].
---------------------
Figure 2-5: A transmission line circuit. The elementary component is enclosed by the
dashed box. The transmission line is a series of elementary components. With the inductor-
capacitor pairing, pulse wave propagation is generated.
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Figure 2-6: Pressure-area during systole. One cycle of the ABP waveform is shown. Stroke
volume is believed to be proportional to the area of the shaded region. Figure adapted from
[10].
2.3 Lumped-parameter, instantaneous flow methods
Two of the CO estimation methods investigated in this thesis use lumped parameter models
to calculate the instantaneous pulsatile flow, q(t), from ABP waveforms. Once q(t) is
obtained, then beat-to-beat CO is the time-averaged flow over a cardiac cycle:
Q= jq(t)dt
2.3.1 Godje nonlinear compliance [6]
Godje's cardiovascular system model is shown in Figure 2-7. Compared to the Windkessel
model, an aortic impedance element, Z, is added, and the heart becomes a pressure source
rather than a flow source. Also, arterial compliance is nonlinear. The expression for arterial
compliance is optimized to minimize mean square error of the flow (derivation for the
optimization is not given in the paper):
p3
C = t)R - (dP(t)/dt) ' 3PP(t) - 3P-P
Using Kirchhoff's current law, instantaneous flow is obtained:
P(t)  dP =1 P _t)_+_m_____ dP(t)/dt
R dt R 3PmP(t) - 3Pm - P(t)2  (dP(t)/dt)
Z
R C
q(t)
Figure 2-7: Godje model with nonlinear capacitance and aortic impedance terms.
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2.3.2 Wesseling Modelflow [20]
Wesseling's modelflow method is one of the most complex (Figure 2-8). The circuit is
similar to Godje's but with every circuit element becoming nonlinear. Aortic impedance
is a function of arterial compliance; arterial compliance is a function of pressure; systemic
resistance is a function of pressure divided by flow. The nonlinear relationship between C
and P(t) are based from Langewouters et al.'s [11] regressions.
P(t) + R C
q(t)
Figure 2-8: Wesseling's modelflow model.
2.4 Limitations of CO estimation
The 11 methods of estimating CO from ABP waveforms have several limitations. First, all
methods require at least one calibration to obtain absolute CO values in liters per minute.
Without calibration from a CO measurement such as thermodilution, one can only obtain
relative estimates, which are still beneficial to the clinicians, especially if CO changes by a
substantial fraction in a given patient.
The cardiovascular models used to estimate CO are vastly simplified from reality, even
for the most complex ones. First, although the pressure-area under systole methods are
based upon the distributed arterial tree, the theoretical foundations are not firmly estab-
lished [19, 10]. It would be beneficial to derive an expression for CO from transmission
line theory. Second, many of the methods assume that a central ABP waveform (such as
one from the aorta) is used. Clinically, radial ABP waveforms are by far more popularly
measured. Figure 2-9 shows that there is a substantial difference between ABP waveforms
in aorta versus radial arteries, though there are models that attempt to estimate the aor-
tic waveform using the radial artery waveform. Lastly, systolic area calculations require
detecting the end of systole, which is completely nontrivial in radial ABP waveforms. In
aortic ABP, the dicrotic notch signifies the end of systole. In radial ABP, the dicrotic notch
is masked by wave reflections and high frequency signal attenuation.
150 - Radial
1:: F Aorta
50 -
Figure 2-9: Pressure waveforms in aorta versus radial artery. Notice that systolic pressure
in the radial artery tends to be higher than that of the aorta. Figure adapted from [15].
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For several reasons, the more complex methods may perform worse than the simpler
ones. First, due to corruption susceptibility of the ABP waveform, especially in a clinical
setting, complex methods may falter if a particular ABP feature is corrupt. The simplest
method, CO is proportional to mean arterial pressure, is by far most robust to noise because
of its averaging nature. Second, the more complex methods have more circuit components.
Wesseling's modelflow method determines the value of each component through ABP wave-
forms and regressions using age and gender. Regression lines were determined from a very
small population (less than 50), which may not be representative of the entire human pop-
ulation. Therefore, modelflow may only perform well on patients with similar physiology
to Wesseling's small study population.
A fundamental limitation of CO estimation performance is due to ABP waveform quality.
Features and morphology of the ABP waveform need to be clean, especially for the more
complex CO estimation methods. Thus, CO estimation is likely to fail in patients with
intra-aortic balloon pumps, valve regurgitation diseases, and long-lasting arrhythmias such
as atrial fibrillation.
Further discussion on the limitations of CO estimation can be found in an editorial by
Lieshout and Wesseling [18].
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Chapter 3
Signal Abnormality Indexing
3.1 Introduction
Cardiac output (CO) estimation from arterial blood pressure (ABP) waveforms rely on
a clean ABP waveform, in which beat-to-beat features such as mean pressure, duration of
systole, and beat period may be reliably obtained. Noisy, artifactual, damped, and irregular
(not sinus rhythm) ABP waveforms may easily lead to bizarre CO estimates. Figures 3-1, 3-
2, 3-3, 3-4 show examples of clinical ABP waveforms from MIMIC II in which CO estimates
are likely to fail. Therefore, it is important to design an algorithm that can flag anomalous
beats in the ABP waveform (Figure 3-4). We define a beat as anomalous when any feature
in the beat becomes obscured. Median filtering helps to reduce some sporadic anomalies,
but fails as anomalies become more frequent.
In this chapter, we present the signal abnormality index (SAI). The algorithm outputs
at a beat-level time resolution and intelligently detects abnormal beats by imposing a series
of constraints on physiologic, noise/artifact, and beat-to-beat variability. SAI does not
distinguish between anomalies arising from physiologic disturbances such as an arrhythmia
and non-physiologic phenomena such as noise.
The SAI algorithm was evaluated on clinical ABP waveforms of 120 patients from
MIMIC II (see Section 1.1.3). Using the 120 records, we quantified the performance of
the SAI algorithm in 3 ways: comparing the algorithm's performance to a human expert,
analyzing the sensitivity of the algorithm's output, and determining whether cleaner wave-
form segments yield better CO estimates.
3.2 Methods
Figure 3-5 shows an overview of the SAI algorithm. First, a beat detection algorithm [22]
marks the onset of each beat. The onset markers allow for feature extraction at beat-level
resolution. For each beat, features such as heart rate, systolic blood pressure, diastolic blood
pressure are obtained. Features are then evaluated by a series of abnormality criteria, which
check for noise level, physiologic ranges, and beat-to-beat variations. The output of each
abnormality criterion is binary, '0' for no flag (clean beat) and '1' for flag. Finally, the
outputs of all abnormality criteria are combined via the logical OR operation.
Given an input ABP segment of n beats, the overall output (define as y) is a binary
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Figure 3-1: Damped ABP waveform. Top plot shows a 20 minute ABP waveform. Bottom-
left plot is a zoom-in near the earlier part, and bottom-right plot is a zoom-in around the
14th minute. Damping caused the pulse pressure to decay from 60mmHg to 10mmHg.
*- 100
50 - -
0 2 4 6 8 10
time [sec]
Figure 3-2: ABP waveform with disturbance. Beat detection becomes nontrivial and un-
predictable here, giving rise to inaccurate CO estimates. (Upon closer examination of the
patient record, this waveform segment was from a patient who had an 2-to-1 intra-aortic
balloon pump, which generated the middle beat for each group of 3 beats shown.)
'6 200
100
0 2 4 6 8 10
time [sec]
Figure 3-3: Noisy ABP waveform. Noisy beat-to-beat features give rise to inaccurate CO
estimates, especially for the more complicated CO estimators.
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Figure 3-4: ABP waveform with artifacts. Corruption in the first 15 seconds is likely due
to improper catheterization caused by movement. Corruption in 20-22 seconds is likely
a motion artifact. Signal abnormality index (SAI) is shown on bottom, raising a flag in
regions of abnormality.
sequence of length n. For the segment, a cumulative SAI (cSAI) is defined as
n
Y = fraction of flagged beats = nEy[k)
k=1
where y[k] is the SAI of the k-th beat. cSAI, with a continuous domain of 0 < Y < 1, is
a useful measure of the abnormality of an entire waveform segment. (e.g. a segment of 50
beats with 4 flagged would yield a cSAI of 0.08.)
The rest of this section explains several components of the SAI in detail and proposes
methods for algorithm evaluation.
ABP - BeatABP *detection
Abnormality
criterion 1
Feature Logical 
.. 11..
-> extraction OR - .11 .
Abnormality_
criterion N
Figure 3-5: SAI block diagram. Input is an ABP waveform. Output is a binary string,
assigning a value (no flag=0, flag=1) to each beat in the ABP waveform.
3.2.1 Feature extraction
The feature extraction algorithm obtains a set of features shown in Table 3.1. For each
beat, P, and Pd are the local minimum and maximum around the pressure onset point. Pm
is the average pressure between adjacent onsets. T is the time difference between adjacent
onsets. Noise level is defined as the average of all negative slopes in each beat.
3.2.2 Abnormality indexing
With blood pressure features available, the SAI algorithm is ready to interpret them. Table
3.2 lists the criteria for flagging a beat.
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Table 3.1: ABP features
Feature Description
PS Systolic blood pressure
Pd Diastolic blood pressure
P, Pulse pressure (P, - Pd)
Pm Mean arterial pressure
T Duration of each beat
f Heart rate (60/T)
w noise: mean of negative slopes
Feature
PS
Pd
PM
f
P
w
Ps[k] - Ps[k -
Pd[k] - P[k -
T[k] - T[k - 1
Table 3.2: SAI logic
Abnormality criteria
P > 300 mmHg
Pd < 20 mmHg
Pm < 30 or Pm > 200 mmHg
f < 20 or f > 200 bpm
Pp < 20 mmHg
w < -40 mmHg/1OOms
1] |API > 20 mmHg
1] |APd| > 20 mmHg
] AT| > 2/3 sec
The first 5 criteria in Table 3.2 impose bounds on the physiologic ranges of each feature.
For example, any beat with a diastolic pressure of less than 20mmHg is flagged.
The 6th criterion is the noise detector. With high frequency noise, there will be large
negative slopes in the waveform. Based upon this observation and by inspecting ABP data,
we decided that any beat with a mean negative slope less than -40mmHg/1OOms is flagged.
Note that this noise detector is not useful for identifying low frequency noise such as baseline
wander.
The final 3 criteria compare ABP features between adjacent beats. Large sudden changes
in beat-to-beat features are likely indications of abnormality. For example, if the (k - 1)-th
systolic pressure and the k-th systolic pressure differs more than 20mmHg, then the k-th
beat is flagged.
3.2.3 Algorithm evaluation
Using 120 patient records from the MIMIC II database, the SAI algorithm was evaluated
in 3 ways:
1. Compare the algorithm's performance to a human expert in detecting anomalies in
ABP waveform segments. Ideally, the algorithm should be in perfect concordance
with the human.
2. Analyze the sensitivity of algorithm's output to perturbations of each threshold pa-
rameter in Table 3.2. A robust algorithm would be relatively insensitive to such
perturbations.
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3. Determine whether cleaner waveform segments, as indicated by low cSAI values, yield
better CO estimates.
In comparing to a human expert annotator, 246 ABP segments were randomly selected,
each 10 seconds long. For each segment, the SAI algorithm outputs '1' if any beat is flagged
as abnormal, '0' otherwise. Similarly, the human identifies any abnormality and classifies
each segment using the following convention:
-- No irregularity-regular, homogeneous beats with negligible artifacts and
noise.
-+ Minor irregularity-clean waveform with minor timing irregularity of
beats and/or minor artifacts. Key morphologic features are still clearly
identifiable.
±- Irregularity present-all beats similar, but one beat stands out from oth-
ers with timing or shape, and/or artifact present obscuring a portion of
a beat.
++ Major irregularity present-more than one beat patently dissimilar from
other beats, and/or artifact present completely obscuring key features of
beats.
Notice that human annotations have 2 gray zones (-+ and +-), which are used when the
waveform's abnormality is not completely obvious.
For sensitivity analysis, the abnormality criteria are tested independently of each other.
A parameter value in Table 3.2 is perturbed while all other abnormality criteria are not
applied. We observe the impact on cSAI across the entire study population, which includes
over 30 million beats. Sensitivity is defined as follows:
dY
Sensitivity =d -
Ad6 =1
where Y is the cSAI and 0 is the normalized parameter value. Normalization allows for
sensitivity comparison between different abnormality criteria.
We examine the performance of 3 CO estimation algorithms (Table 3.3) as a function of
cSAI. For our study population, a 1-minute ABP segment is extracted at the time of each
TCO measurement. Estimated CO and cSAI are obtained for each 1-min ABP segment.
For the entire population, the error metric is u(CO - TCO), the standard deviation of the
difference between estimated CO and TCO. The error is evaluated as a function of cSAI.
We begin the experiment by examining o- of the entire population with no discrimination
due to cSAI. Then, 1-min segments with high cSAI values (poor waveform quality) are
progressively eliminated. The goal is to determine whether CO estimation error decreases
for cleaner waveforms.
Table 3.3: CO estimators taken from Table 2.1.
CO estimator CO = k - below
Mean arterial pressure Pm
Windkessel P. f
Liljestrand nonlinear compliance p f
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3.3 Results
3.3.1 SAI versus human
Table 3.4 shows the distribution of the 246 comparisons of SAI versus a clinician (ATR).
Note that SAI performance is worse in the two grays zones (-+ and +-). However, only
22% of data fall into these categories. Table 3.5 lists important statistics derived from the
distribution, both exclusive (3rd column) and inclusive (4th column) of the gray zones.
Table 3.4: SAI versus human: distribution
SAI
1 14 13 9 37
0 142 26 5 0
-- -+ +- ++ human
Distribution of the 246 ABP waveform segments. SAI
flag, -+ probably no flag, +- probably flag, ++ flag
key: 0 no flag, 1 flag. Human key: -- no
Table 3.5: SAI versus human: statistical summary
PPV P(+1) 0.73 0.63
NPV P(-10) 1 0.97
Sensitivity P(1I+) 1 0.90
Specificity P(OI-) 0.91 0.86
3rd column excludes gray zones, 4th column includes gray zones. PPV=positive predictive value,
NPV=negative predictive value, P(*I*) are conditional probability notations for PPV, NPV, etc.
3.3.2 Sensitivity analysis
Figure 3-6 plots cSAI as a function of 3 abnormality criteria. Notice that each criterion flags
only a small fraction of beats, and the slope of the curves are not steep but also nonzero
at 0 = 1. Table 3.6 lists the sensitivity of every parameter. The results indicate that our
study population had no waveform with P, > 300mmHg or Pm > 200mmHg.
U-
1
0.6
0.4
0.2
0
-.................- --. .
--- W
0 0.2 0.4 0.6 0.8 1 1.2
$ - normalized thresholds
I.
1.4 1.6 1.8
Figure 3-6: Perturbations to abnormality criteria. cSAI as a function of 3 parameters
perturbations is shown. Sensitivity is defined to be the slope of each curve at 0 1.
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Table 3.6: SAI sensitivity
Feature 9o Y(Oo) ISensitivityl
PS 300 0 0
Pd 30 .010 .003
Pm,min 30 .007 .007
Pm,max 200 0 0
fmin 20 .001 .001
fmax 200 .047 .180
Pp 20 .028 .092
w -4 .027 .160
Ps[k] - Ps[k - 1] 20 .064 .080
Pd[k] - Pd[k - 1] 20 .007 .013
T[k] - T[k - 1] 0.7 .017 .033
3.3.3 Cardiac output estimation error
Figure 3-7 plots CO estimation error as a function of maximum accepted cSAI. Errors
decrease for lower cSAI (cleaner waveform) values. For the Liljestrand algorithm, an error
reduction of 30% is obtained. The mean pressure estimation algorithm is most robust to
noise, as evidenced by its relatively flat line. This robustness is expected because of the
simplicity and averaging nature of the mean pressure algorithm.
3.4 Discussion and conclusions
Evaluating the performance of the SAI algorithm is nontrivial, primarily because of a lack
in the quantitative definition of an 'abnormal' beat of an ABP waveform. Consequently,
there is no established gold standard to compare against. Furthermore, the definition of
abnormality can be application dependent. For example, beat quality needs to be higher
for CO estimation than for mean pressure tracking because more features derived from each
beat are used for the former. From Figure 3-7, a maximum accepted cSAI level of 0.5 can
be routinely used for CO estimation purposes. At cSAI = 0.5, only 10% of the poorest
ABP data have been removed, CO estimation error has been substantially reduced, and the
data quantity does not change very rapidly around this point.
From the sensitivity analysis, two abnormality criteria do nothing and have sensitivity
of 0. Therefore, for our study population, they can be removed. Of the remaining criteria,
pairwise correlation studies can be performed in the future to identify any redundant criteria.
In conclusion, we have presented an algorithm that detects anomalies in the ABP wave-
form. The SAI algorithm is in close agreement with a human expert (Table 3.5), is robust
(Table 3.6), and has proven its effectiveness in its ability to select clean ABP waveforms to
improve CO estimation.
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Cardiac output estimation error
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Figure 3-7: CO estimation error as a function of maximum accepted cSAI. Bottom plot
shows that the amount of data also decreases as we restrict ourselves to cleaner waveforms.
34
Chapter 4
Evaluation Methods
Evaluating the performance of cardiac output (CO) estimation requires obtaining the fol-
lowing signals:
" A set of ABP waveforms as input for the CO estimators. In order to capture the
intra-beat waveform morphology, sampling rate of ABP needs to be sufficiently high
(greater than 60Hz).
" A set of gold-standard CO measurements to compare with estimated CO. Each
measurement must be available simultaneously to ABP waveform recordings. We will
use thermodilution CO (TCO) measurements as gold-standard. It is well known that
TCO has errors itself [17]. Thus, by comparing estimated CO to TCO, our results
are limited by TCO's accuracy.
The signals will be processed by the following systems:
" A data extraction system to identify suitable ABP waveforms and TCO measure-
ments for analysis.
" A CO estimation system to accurately and efficiently implement each CO estima-
tion algorithm. Ideally, we obtain the 11 algorithms from the original creators and
use their exact implementation. However, this is impractical in many ways. Hence,
we peruse their publications and mimic their methods as closely as possible.
" A comparison system to output the error between each estimated CO and TCO.
This system may seem trivial, involving a simple subtraction. However, a major
problem is that all CO estimates are given in relative units (Table 2.1). Therefore,
we must establish suitable calibration methods before performing comparisons. We
also design a scheme comparing percentage changes in estimated CO and TCO. This
scheme does not require calibration.
" An error analysis system to report the performance of CO estimates across the
entire study population. We also explore the physiologic conditions in which CO
estimators are likely to fail. Using these analyses, our goals are (1) to determine
whether CO estimates are reliable enough for clinical use, and (2) to investigate the
possibility of improving CO estimates.
Figure 4-1 presents a high-level flow chart showing the connectivity between the signals and
systems outlined above. This chapter discusses each component in detail.
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Figure 4-1: A system for evaluating CO estimation performance.
4.1 Data extraction
Relevant source code: wavex.m, trendex.m 1
As described in Chapter 1, the clinical database we use is MIMIC II, which contains phys-
iologic waveform data from over 3500 ICU patients hospitalized at Beth Israel Deaconess
Medical Center, Boston, USA. From this database, we identified 120 patients with simul-
taneously available ABP waveforms and TCO measurements. The ABP waveforms are
measured radially and stored as 8-bit quantized data with a temporal resolution of 125Hz.
TCO is measured intermittently with a temporal resolution of 1 minute.
4.2 Implementation of CO estimators
With appropriate ABP waveforms extracted, we are now ready to make CO estimates.
Figure 4-2 presents the flow chart showing the transformation of ABP into beat-by-beat
CO. The first step is to detect beats in the ABP waveform. For each beat, various features
such as instantaneous heart rate, systolic blood pressure, and pulse pressure are extracted.
Given the features, the CO algorithms output CO estimates. The signal abnormality indexer
identifies abnormal beats and eliminates them. Finally, we apply a low-pass filter and
eliminate fluctuations in CO estimates caused by beat-to-beat variations. The rest of this
section discusses each major block of the CO estimation system in detail.
ABP 4.2.1ABP >Beat detection
onsr markers
4.2.2 4.2.3
Beat-to-beat - - CO estimation
1feature extraction algorithms "424..5b 
a-o e t4.2.44.2.sbeat-to-beat
Bad estimates -- Low-pass filter -i
PIP, HR, .. elimination (optional) CO estimate
4.2.4
Signal abnormality-
Indexing
Figure 4-2: Data flow diagram for CO estimation.
4.2.1 ABP beat detection
Relevant source code: wabp.m
The beat detection system segments the ABP waveform into individual beats. The process
'See Appendix B for MATLAB source code descriptions.
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is essential in extracting ABP features. We adopt an algorithm designed by Zong et al.
[22] that robustly detects the onset of each beat in the ABP waveform. The basis of Zong's
onset detection algorithm is the slope sum function (SSF), which amplifies the rising part
of each beat (Figure 4-3). More details can be found in their paper.
4-3: The slope sum function (SSF). It aids in onset detection. Figure adapted from
4.2.2 ABP feature extraction
Relevant source code: abpfeature .m
After segmenting the ABP waveform into individual beats, we extract useful features from
each beat. The complete set of extracted features is listed in Table 4.1.
Table 4.1: ABP features
Feature Description Units
P Systolic blood pressure mmHg
Pd Diastolic blood pressure mmHg
Pp Pulse pressure (P, - Pd) mmHg
Pm Mean arterial pressure mmHg
As pressure area during systole (2 methods) mmHg-sec
w mean of negative slopes (for noise detection) mmHg/sec
T Duration of each beat sec
TS Duration of systole (2 methods) see
Td Duration of diastole (T - T,) sec
Figure 4-4 shows the identification of P,, Pd, and Pp. P, is the local maximum within
a time window following each onset. Likewise, Pd is the local minimum within a window
before each onset. P, is the difference between P, and Pd. Pm is the average of all pressure
samples between adjacent onsets. T is the time difference between adjacent onsets. Noise
level is defined as the average of all negative slopes in each beat.
As described in Chapter 2, many CO estimators require the detection of end-of-systole.
End-of-systole's defining feature in the aortic pressure waveform is the dicrotic notch, mark-
ing the time in which the aortic valve closes (Figure 4-5). Unfortunately, wave reflections
and high frequency signal attenuation in the radial arteries completely mask the dicrotic
notch. However, publications often mistakenly associate the second peak of each beat as
the dicrotic notch. The second peak is not the dicrotic notch but a reflected wave.
This nontriviality in end-of-systole detection lead us to employ two techniques to ap-
proximate end-of-systole, the RR method and the "first zero slope" (FZS) method. The
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Figure 4-4: Ps, Pd, and P, detection. The light dot marks the onset. The darker dots are
P, and Pd. The line segment marks P,. The shaded areas are the two search windows for
P, and Pd.
RR method uses a result from electrocardiography. QT-interval duration is approximated
as 0.3/RR interval [1], where RR-interval is measured in seconds. Intuitively, the QT frac-
tion becomes smaller as the duration of a cardiac cycle lengthens. We approximate that
the RR-interval equals the beat period. The QT-interval is the duration from electrical
depolarization to repolarization of the ventricles. Therefore, for a normal healthy heart, we
approximate the QT-interval and systolic ABP duration to be very similar. From Figure
4-5, these approximations are reasonable. Hence, T, = 0.3x/T. For the FZS method, we find
the first time following P, that the slope of ABP becomes 0. Preliminary testing showed
that while the 2 methods may indicate significantly different end-of-systole times (Figure
4-6), both offered very similar results in terms of CO estimation performance.
The main purpose for end-of-systole detection is in calculating the area under ABP
during systole of each beat. Figure 4-6 shows end-of-systole and systolic area.
As = f(P(t) - Pd)dt
T,
4.2.3 CO estimator implementation
Relevant source code: estO<num>_<title>.m
The first 9 CO estimators in Table 2.1 take features of the ABP waveform as input. Simple
arithmetic operations are applied to produce beat-to-beat CO estimates. The last 2 esti-
mators use beat-to-beat features and the raw ABP waveform. Differential equations are
used to produce a flow waveform. Then, we integrate the flow waveform over the systolic
duration to produce CO estimates.
4.2.4 Signal quality and bad beats elimination
Relevant source code: jSQI.m, estimateCO.m
Quality of the ABP waveform is essential in determining the performance of CO estimators.
Noisy, artifactual, damped, and irregular (not sinus rhythm) ABP waveforms may easily
lead to bizarre CO estimates. Figures 3-1, 3-4, 3-2, 3-3 from Chapter 3 show examples of
ABP waveforms from MIMIC II in which CO estimates are likely to fail. In Chapter 3, we
presented the SAI algorithm to flag abnormal beats in the ABP waveform. Flagged beats
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area. The light dot marks the onset. End of systole
dot and by the FZS method is the later dark dot.
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do not participate in CO estimation. Also, if a substantial percentage of beats are flagged
in a given segment, the entire segment is excluded from CO estimation.
4.2.5 Running-average LPF to reduce beat-to-beat fluctuations
Relevant source code: estimateCO.m
Stroke volume varies on a beat to beat basis due to varying filling pressures caused by
respiration. This phenomena occurs in every individual albeit in different magnitudes. For
continuous tracking of CO, we would have beat-to-beat fluctuations if we simply apply CO
estimation methods to each beat (Figure 4-7). Also, CO is a quantity more meaningful
on the time scale of minutes rather than individual beats. Therefore, we apply a running-
average low pass filter with a window of at least 10 seconds on all features extracted from the
ABP, thereby obtaining an averaged stroke volume (hence CO) with much less inter-beat
variability.
100- -
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50
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time [sec]
Figure 4-7: Beat-to-beat variability in ABP waveform due to respiration. P, varies between
35 and 45mmHg, which can cause beat-to-beat CO estimates to have 25% fluctuations.
4.3 Comparing estimated CO to gold-standard CO
Relevant source code: evco.m
The goal of the comparison system is to report errors between estimated CO and gold-
standard CO (thermodilution CO in our study). Let's define x as the estimated CO pro-
duced by one algorithm and r as the corresponding TCO measurement. Then, error is
defined as:
e = x - r
There are two important complications that underly a seemingly simple subtraction:
" For each r, there are many beat-to-beat values of x. We need to average x over a
suitable window.
" As shown in Table 2.1, CO estimates are in relative units. Thus, before comparing to
TCO in units of liters per minute, we need perform a calibration in order to determine
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the proportionality constant k.
Large percentage rises or drops in CO are of clinical interest. We devise a method to report
the accuracy of CO estimates in determining percentage changes without calibration.
4.3.1 Averaging beat-to-beat CO estimates
In MIMIC II, TCO measurements are recorded with a 1-minute temporal resolution. There-
fore, it is sensible to take the average CO estimate over the 1-minute window immediately
preceding the TCO measurement. Figure 4-8 shows that a 1-minute averaged CO estimate
is indeed robust to beat-to-beat fluctuations. Mathematically, our averaged CO estimate
becomes:
1 T
x; = -
k=:T-N+1
a[k]
where a[k] is CO
measurement, N
surement.
estimate at the k-th beat, a[T] is the CO estimate closest to the TCO
is the number of beats in the 1-minute window prior to the TCO mea-
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Figure 4-8: Window size for averaging CO estimates. Mean and standard deviation of a
CO estimate (relative units) are shown as a function of window size. Notice that the two
trends reach steady state after 10 seconds, suggesting that a minimum averaging window
of 10 seconds is required in order to avoid beat-to-beat fluctuations.
4.3.2 Calibration techniques
For each patient, we calibrate each estimator in 3 ways (denoted as C1, C2, C3), each
tailoring towards a different use model. In two of the calibration methods, we use a vector-
based approach. For a patient with N TCO measurements, we construct an N-dimensional
column vector, with one dimension for each measurement:
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Reference CO (TCO): r = [r, r 2  - rN]'
Uncalibrated estimate: x = [x1 X2 - XNI
Calibrated estimate: q = kx
kx X
Figure 4-9: Vector visualization of TCO and estimated CO. For C1, we choose k to minimize
error (magnitude of the dashed vector).
Cl: Optimal single k. We choose a single constant k to minimize the mean square
error. Using linear algebra, the optimal k is given as:
r'xk= , (Cl)
x x
C2: Optimal previous k. C1 calibration is useful in obtaining a lower bound of error
for each estimator. However, C1 is noncausal and hence unsuitable in a live clinical setting.
Therefore, for online estimation, we update our optimal k using previous data points. For
the i-th k, we calibrate using the previous (i - 1)-dimensional vector:
k= -1xi (C2)X- 1 x- 1
Now the calibrated estimate becomes:
q= [klx1 k2 x2 -.. kNXN]'
C3: First point single k. TCO measurements are usually taken very infrequently.
Therefore, it is also useful to know the estimator performance by calibrating only to the
first TCO measurement:
k = (C3)
X1
The most prominent problem for C3 calibration: if x1 is unusually noisy, producing an
absurd calibration constant, the rest of CO estimates will be strongly affected. Consider
the example: x = [20 50 20 30 40 and r = [1 5 2 3 4] L/min. Clearly, a good calibration
constant would be k = 0.1, but the C3 method would yield k = 0.05.
4.3.3 Relative CO estimation
Outside of the ICU setting, invasive measurements of CO are likely unavailable; thus, we
cannot calibrate to produce an absolute CO estimate. However, it would still be useful to
know percentage changes in CO, especially if the changes are significant. For example, if
the true CO decreased by 50%, we would like to know if the estimated CO has decreased
by a similar percentage.
For each of the 120 patients, we search for the pair of TCO measurements with the
largest difference in value. Then, the corresponding percentage change in the estimated CO
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(Ax) and TCO (Ar) are compared. Mathematically:
-~ 1~ x 100
- 1 x 100
rii] 
_1 X 100
-r[imaxJ x
(X~mx 1~ X 100
X FiminI /
~XlimacJ
if t[imax] > t[imin]
if t[imax] < t[imin]
if t[imax] > t[imin]
if t[imax] < t[imin]
where imax is the index in which maximum TCO occurs, and correspondingly for imin-
4.4 Error analysis
In the previous section, we established methods to obtain the error between each TCO
measurement and estimated CO. Across the entire study population, for each CO estimator,
we have an error distribution. In clinical literature, the most popular representation of error
distributions is the Bland-Altman plot [3]. Figure 4-10 shows an example. The horizontal
axis is the average of TCO and estimated CO. The vertical axis is the error. The major
advantage of such a plot is that it enables one to see whether there's any correlation between
the error and the averaged CO. For example, if error becomes substantial for high CO, then
the estimated CO should not be trusted whenever it gives a high CO value.
CO estimator: Liljestrand & Zander
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Figure 4-10: A sample Bland-Altman plot. The error histogram is shown on the left. The
solid lines show 1 SD bounds, and the dashed lines show 95% confidence intervals.
With the aid of Bland-Altman plots, we present the performance of each CO estimator in
the following ways:
CO estimation error. We report the 1SD and 95% confidence interval of the error dis-
tribution. If the error distribution is Gaussian, the numerical values for the 95% confidence
interval and 2SD coincide.
k-variability. A good CO estimator should have a calibration constant (k) with low
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kx_
variability across different patients. For example, if one ideal CO estimator has k = 5 ± 0.01
for all of the 120 patients, then we can assume k = 5 and obtain the absolute CO estimate
for any patient. However, if k = 5 ± 5, then calibration is necessary for each patient.
Mathematically, we quantify k-variability as:
k-variability =SD of k for the study population a-(k)
mean of k for the study population y(k)
Division by p(k) enables us to compare the variability of k among different CO estimators.
A k-variability of 0.1 would mean that the k fluctuates by 10% around the mean.
CO-variability. A good CO estimator should produce beat-to-beat CO estimates with
variability on the order of stroke volume and heart rate variability. It is undesirable for
the stroke volumes to fluctuate beyond physiologically plausible ranges from beat-to-beat.
CO-variability is measured for each 1-minute ABP waveform in which we obtain beat-to-
beat CO estimates (no LPF is applied here). We assume that the physiological state is
stable (e.g. average CO is constant) over the 1-minute window. Similar to k-variability,
CO-variability is defined mathematically as:
CO-variability = SD of CO for a 1-min ABP waveform o(q)
mean of CO for a 1-min ABP waveform p(q)
For each CO estimator, we report the average CO-variability over the entire study popu-
lation. Because of the division by p(CO), calibration is not necessary to determine CO-
variability.
Relative CO estimation error. A good CO estimator, when uncalibrated, should
still agree with TCO in terms of percentage increases and decreases. As discussed in Section
4.3.3, for each patient we identify the pair of data points with most significant change in
TCO and compare it to the corresponding estimated CO. Figure 4-11 shows an example
of relative CO estimation performance. For each CO estimator, we report the 1SD of the
error distribution between percentage changes in estimated CO and TCO. We also report
the performance of detecting directional changes, defined as:
P(+I+) = probability of an increase in estimated CO given an increase in TCO
P(-I-) = probability of an decrease in estimated CO given an decrease in TCO
Subset error analysis. A CO estimator may perform better in certain physiologic
conditions than others. In subset error analysis, we show interesting plots of CO estimation
error as a function of ABP features such as heart rate and mean arterial pressure. For
example, a possible discovery would be that one CO estimator performs worse in high heart
rates than low heart rates.
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Figure 4-11: Percentage changes in TCO versus estimated CO. Ideally, every point lies on
the diagonal line. A point that lies in one of the two shaded zones means that the estimated
CO and TCO agree in terms of directional (increase/decrease) change.
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Chapter 5
Results and Discussion
5.1 Subject population statistics
First we report the characteristics of the 120 patients studied. Figure 5-1 shows distributions
of various population statistics. Table 5.1 lists the the statistical summaries.
Remarks. Although only 78 out of 120 had age data, our study population is mainly
composed of the elderly, with no patient under age 40. There are over 1400 TCO measure-
ments with an average value of 5 L/min, which is "textbook normal". Patients typically
have a TCO range of 2.5 L/min, which is significantly larger than previous studies of CO
estimation performance using human subjects. On average, each patient has 12 TCO mea-
surements over 2.3 days, which is 1 TCO measurement per 4.6 hours. The scarcity in TCO
measurements shows the need for CO estimates to fill in the gaps. Mean arterial pressure
(Pm) is slightly hypotensive at 75mmHg.
Ta
statistic
age
stay duration
TCO quantity
ATCO per patient
AP, per patient
APVR per patient
cSAI
TCO
Pm
heart rate
PVR
ble 5.1:
mean
69
2.3
12
2.5
26
0.5
0.2
5
75
90
1
Population statistics
SD
12
2.2
9
1.2
11
0.3
0.3
2
10
20
units
years
days
N/A
L/min
mmHg
mmHg.s/ml
N/A
L/min
mmHg
bpm
0.4 mmHg.s/ml
n
78
120
120
120
120
120
1436
1436
1351
1351
1351
Peripheral vascular resistance (PVR) is the ratio of TCO and Pm.
5.2 Removal of poor quality waveforms
As explained in Chapters 3 and 4, waveform quality plays a key role in CO estimation
performance. Therefore, ABP waveform segments of poor quality should not be included
as part of our performance study. Figure 5-1(c) shows the quality distribution of the 1436
47
distribution (n = 78, p = 69, a = 12)
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Figure 5-1: Population statistics.
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1-min ABP waveforms segments using the cSAI metric. For cSAI, "0" is clean and "1" is
completely poor. The majority of waveforms are clean. Based upon this distribution and
results shown in Figure 3-7, we decided to only use waveform segments with cSAI < 0.4
for our analyses. Figure 5-2 shows the Bland-Altman plot of the Liljestrand algorithm with
different levels of signal quality: In (a), all segments are used. In (b), only waveforms with
cSAI < 0.4 are used. In (c), only the pristine (cSAI = 0) waveforms are used. Notice
even in (a), the number of comparisons is 1230, not 1436. This is because 120 were used
for calibration and the remaining 86 had waveforms of so low quality that features could
not be extracted from them. For the rest of this chapter, we only examine CO estimation
performance on ABP waveforms with cSAI < 0.4.
5.3 Absolute CO estimation
Table 5.2 shows the error of the 11 CO estimators with 3 different calibration methods.
Cl-calibrated Bland-Altman plots along with error distributions are shown in Figures 5-3
and 5-4. A brief discussion on the statistical significance of the difference between the error
distributions can be found in Appendix C. From these results, the best CO estimator is
clearly Liljestrand's nonlinear compliance method. Optimal C1 calibration yields a 1 SD
error of 0.79 L/min. Most other estimators have errors between 0.9 and 1 L/min. Godje and
Wesseling modelflow methods generate particularly large errors. Out of curiosity, we report
the error of a hypothetical CO estimator, which maintains constant for each subject. When
Cl-calibrated, for each subject the constant is close to the mean TCO. When C3-calibrated,
that constant is the value of the first TCO data point. The results (last row of Table 5.2
and Figure 5-4f) show that such a constant outperforms all except the Liljestrand method,
which indicates that the Liljestrand method is the only method suitable for calibrated CO
estimates.
Table 5.2: Estimation error in L/min at 1 SD with 3 different calibration methods. 95%
confidence interval errors shown in parentheses. See
of each calibration method.
Error C1
Mean arterial pressure 0.97
Windkessel 0.98
Windkessel RC decay 0.99
Herd 1.11
Liljestrand nonlinear compliance 0.79
Systolic area 0.93
Systolic area with correction 0.95
Systolic area with corrected impedance 0.91
Pressure root-mean-square 0.98
Godje nonlinear compliance 1.69
Wesseling Modelflow 1.61
Constant CO 0.82
section 4.3.2
(2.01)
(1.90)
(2.00)
(2.27)
(1.59)
(1.90)
(1.90)
(1.81)
(1.91)
(3.63)
(3.37)
(1.66)
C2
1.14
1.18
1.19
1.33
0.95
1.10
1.13
1.08
1.19
3.25
1.97
0.98
(page 42) for the definition
(2.33)
(2.32)
(2.26)
(2.62)
(1.96)
(2.21)
(2.23)
(2.14)
(2.31)
(5.20)
(3.81)
(2.04)
C3
1.55
1.46
1.46
1.62
1.19
1.41
1.42
1.35
1.47
5.60
2.80
1.36
(3.30)
(2.90)
(2.90)
(3.40)
(2.43)
(2.95)
(3.05)
(2.84)
(2.95)
(10.94)
(6.09)
(2.70)
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Bland-Altman plot (n = 1230, u(error) = -0.11, a(error) = 0.98)
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Figure 5-2: Bland-Altman plots of the Liljestrand CO estimator with various levels of ABP
waveform quality: from all inclusive (a) to only the most pristine data (c).
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Figure 5-3: Bland-Altman error analysis plots for each CO estimator. The error distribution
is shown to the left of each plot. Solid horizontal lines show 1 SD bounds, and dashed lines
show 95% confidence intervals.
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Figure 5-4: Bland-Altman error analysis plots (continued).
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5.4 Variability of calibration constants
Table 5.3 shows the variability of C1 and C3 calibration constants across the study popu-
lation. Liljestrand CO estimator has the lowest C1 and C3 variabilities of 38% and 42%,
respectively. These numbers are quite high, indicating that we still must calibrate each
patient individually in order to obtain absolute CO estimates.
Table 5.3: Variability of k for
Estimator
Mean arterial pressure
Windkessel
Windkessel RC decay
Herd
Liljestrand nonlinear compliance
Systolic area
Systolic area with correction
Systolic area with corrected impedance
Pressure root-mean-square
Godje nonlinear compliance
Wesseling Modelflow
C1 and C3 calibration.
Cl variability C3 variability
0.40 0.50
0.42 0.48
0.43 0.49
0.47 0.55
0.38 0.42
0.43 0.48
0.44 0.49
0.43 0.48
0.43 0.48
0.62 1.75
0.42 0.51
5.5 Variability of CO estimates
Table 5.4 shows the average variability of beat-to-beat CO estimates obtained from 1-
minute ABP waveforms. The Pm CO estimator has the lowest variability of 4%. The more
complex estimators have higher variability. These results are plausible because the Pm
estimator takes simple averages of all ABP samples whereas the more complex estimators
use individual features from the ABP waveform. We do not have the means to prove which
CO estimation method has variability levels that closest resembles reality. However, a 10%
or less variability in stroke volume does seem reasonable.
Table 5.4: Variability of CO estimates.
Estimator Variability
Mean arterial pressure 0.04
Windkessel 0.09
Windkessel RC decay 0.10
Herd 0.12
Liljestrand nonlinear compliance 0.07
Systolic area 0.09
Systolic area with correction 0.10
Systolic area with corrected impedance 0.10
Pressure root-mean-square 0.09
Godje nonlinear compliance 0.26
Wesseling Modelflow 0.67
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5.6 Relative CO estimation
Figures 5-5 and 5-6 plot percentage changes of estimated CO versus percentage changes
in TCO for the 11 CO estimators. Some patients had 50% drops in TCO while others
had almost 200% increases. With this large range of TCO increases and decreases, none of
the CO estimators are closely clustered around the diagonal line, with the Pm, Godje, and
Wesseling modeflow estimators being particularly unsatisfactory. Even the best estimators
generate 1 SD errors of 44%. The complete results are reported in Table 5.5. Note that the
1 SD error values should be interpreted with caution due to lack of symmetry: While drops
in CO cannot exceed 100%, rises in CO is mathematically unbounded.
However, some estimators work reasonably well in terms of predicting directional (in-
crease/decrease) change. The systolic area with corrected impedance method predicted CO
increases correctedly 81% of the time, while the Herd method predicted CO decreses cor-
rectedly 83% of the time. Note that the constant CO estimator (Figure 5-6f) doesn't work
at all for relative CO estimation. Also, the mean arterial pressure CO estimator has a much
smaller dynamic range compared to TCO, as witness by the relatively flat scattergram in
Figure 5-5a. This agrees with the cardiovascular physiology theory that the mean pressure
is actively controlled (stabilized) to some set point.
Estimator
Mean arterial p
Windkessel
Windkessel RC
Herd
Liljestrand nonI
Systolic area
Systolic area wi
Systolic area wi
Pressure root-n
Godje nonlinea
Wesseling Mod(
Constant CO
Table 5.5: Relative CO estimation error.
1SD error P(+I+)
ressure 53% 0.49
48 0.77
decay 47 0.78
48 0.76
inear compliance 46 0.80
46 0.77
th correction 45 0.78
th corrected impedance 44 0.77
ean-square 46 0.81
compliance 105 0.45
Ilflow 74 0.44
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5.7 Error analysis of selected CO estimators
The Liljestrand method clearly performed the best in absolute CO estimation, had plausible
variability levels, and was above average in relative CO estimation. Examining at a finer
detail, we now analyze its error as a function of several physiologic parameters. As shown in
Figure 5-7, the Liljestrand method becomes more accurate when (a) mean arterial pressure
is high, (b) pulse pressure is high, (c) heart rate is low, (d) its own CO estimate is low,
(e) systemic resistance is high, and (f) TCO is low. Therefore, when some or all of these
conditions are met, we can trust the values given by the Liljestrand algorithm.
The mean arterial pressure method offered similar error characteristics (Figure 5-8 as
the Liljestrand method, albeit with larger error magnitudes. The Wesseling Modelflow
method has errors of even greater magnitude, as shown in Figure 5-9. Note that the error
is especially high if the estimated CO is high (Figure 5-9d).
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Figure 5-5: Performance of percentages changes in CO. The perfect CO estimator would
have data points clustered on the line of identity. Points that fall into the shaded regions
signify that the estimator correctedly determined the directional change in CO.
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Figure 5-7: CO estimation (Liljestrand method) error as a function of several variables.
Each variable is segmented into low, medium, and high regions with equal quantity. Rect-
angular bars represent the 95% confidence intervals.
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5.8 Selected time series case studies
Up until now, this chapter has focused upon reporting error statistics of each CO estimator.
The champion is the Liljestrand method. In this section, we selected two subjects to examine
the time series data of Liljestrand CO estimates.
Subject: caselD 8463. This subject has 14 TCO measurements between 3.4 and 5.8
L/min. As shown in Figure 5-10, the error between TCO and Liljestrand estimated CO is
small. The large increase and decrease in TCO between minute 1000 and 1700 are captured
by corresponding dynamical changes in mean pressure and heart rate.
Subject: caselD 6629. This subject is a 70 year old male with aortic valve disease. His
5 TCO measurements are between 5.2 and 7.3 L/min. His left ventricular ejection fraction
is 41%, which is lower than the normal range of 55-75%. As shown in Figure 5-11, the
error between TCO and Liljestrand CO estimates is more prominent here: TCO increased
significantly from the 3rd to 4th TCO measurement while pulse pressure, mean pressure,
and heart rate remained relatively constant in this time frame, which collectively yields a
constant Liljestrand CO estimate.
5.9 Discussion
One burdening question: Are CO values, when estimated from the ABP waveform, accurate
enough for clinical use? The answer is not so simple. First, we must revisit the accuracy
of thermodilution CO (TCO). According to Stetz et al. [17], TCO has a 1SD error of
about 10%, which is 0.5 L/min when assuming a nominal CO of 5 L/min. Comparatively,
the Liljestrand estimator generated errors of 0.8 L/min when optimally calibrated and 1.2
L/min when scantily calibrated. Thus, the best CO estimation method has an error that is
approximately twice that of TCO. Now, is twice the error still accurate enough for clinical
use? Clinicians typically care most about substantial changes in CO. For each patient in
our study population, the average TCO range was 2.5 L/min (Table 5.1). For a change in
CO of 2.5 L/min, the Liljestrand method should certainly be able to distinguish such an
event.
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Figure 5-10: Time series of caselD 8463 using the Liljestrand CO estimator. (a) Bland-
Altman plot with estimation error from caseID 8463 highlighted. (b) Top plot shows con-
tinuous Liljestrand CO estimates with TCO data points superimposed. Bottom 3 plots
shows the components of the Liljestrand CO estimator: pulse pressure, mean pressure, and
heart rate.
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the previous subject, CO estimation performance is worse here. TCO increased significantly
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Chapter 6
Conclusions and Future Research
6.1 Summary
In this thesis we have presented and evaluated 11 of the established cardiac output estima-
tion methods using ABP waveform data from the MIMIC II database.
Chapter 2 discussed the theoretical basis of each CO estimation method. The simplest
method was based upon a drastically simplified model of the cardiovascular system. The
most complex method, Wesseling's modelflow, was based upon a model with many nonlin-
earities in an attempt to more accurately characterize the dynamics of the cardiovascular
system. Chapter 2 concluded with a discussion on the fundamental limitations of estimating
CO using ABP waveforms.
Chapter 3 addressed one limitation that hindered CO estimation performance: ABP
waveform quality. The signal abnormality index (SAI) algorithm presented in this chapter
attempted to flag regions of ABP waveform of poor quality. In defining what constitutes a
poor ABP waveform, we tried to be as objective as as possible. Output of the algorithm
was mostly in concordance with a human expert and proven to be effective in reducing CO
estimation error.
Chapter 4 presented our methods for evaluating the CO estimators. We designed algo-
rithms to extract pressure and temporal features from the ABP waveform. We integrated
the SAI algorithm to ensure that extremely poor ABP waveforms are eliminated. We de-
signed calibration techniques, which is necessary for CO estimators to produce absolute
values in liters per minute. In absence of calibration, we presented a technique to compare
percentage changes in gold-standard CO with percentage changes in estimated CO.
Chapter 5 showed the performance of the 11 CO estimators. For absolute CO estima-
tion, the Liljestrand CO estimator was clearly the champion. It generated errors of 0.8
L/min when optimally calibrated and 1.2 L/min when scantily calibrated. Whether such
specifications are meritable for clinical use is ultimately up to the decision of a clinician.
However, it should be noted that patients with life-threatening problems often have CO
fluctuations significantly beyond 1.2 L/min. For each patient in our study population, the
average thermodilution CO range was 2.5 L/min. Thus, the Liljestrand estimator should
be able to detect such large changes in CO.
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6.2 Suggestions for future research
As this thesis draws to a close, inevitably there are research tasks not accomplished but
would be plausible extensions of this thesis. There are also interesting research tangents to
embark on.
Algorithmic improvements. As evidenced by the 11 CO estimators studied in this
thesis, previous research on improving CO estimation have been mostly in the creation of
new methods from first principles or in the modification of existing methods. An alternative
approach to improve CO estimation is to optimally combine the existing methods. It is likely
that one CO algorithm works better than another under different physiologic situations.
The detailed error analysis of the Liljestrand algorithm (Figure 5-7) clearly shows that
this algorithm is more accurate when mean arterial pressure is over 80mmHg, heart rate
is less than 80bpm, estimated CO is less than 5L/min, and systemic resistance is greater
than 1 mmHg-s/ml. We can perform similar error analysis on the remaining 10 algorithms,
perhaps as a function of even more physiologic information obtained from lab tests and
nursing notes. Then, a master algorithm may be developed to optimally choose the CO
estimator(s) that will likely be most accurate for each particular patient.
The Signal Abnormality Index (SAI) algorithm works reasonably well but certainly
has potential for improvement. The current SAI logic is composed of a series of static
criteria imposed on pressure values and beat-to-beat durations (Table 3.2). Each criterion
is independent of each other. One possible improvement would be to dynamically change
the thresholds for each criterion. For example, beat-to-beat variations of systolic blood
pressure is likely larger in patients with large pulse pressure than ones with small pulse
pressure. Thus, abnormality criteria 7 in Table 3.2 should be a function of pulse pressure
rather than the constant value of 20mmHg. However, with rising complexity, the degrees of
freedom in the algorithm rises, and one must attempt to avoid over-training the algorithm
to a particular data set.
Live clinical evaluations. All research in this thesis have been in analyzing data retro-
spectively. It does not prove that continuous cardiac output monitoring with such a level of
accuracy can indeed aid in clinical decision making. It would be an interesting investigation
to build a CO bedside monitoring system (perhaps in addition to providing CO estimates,
the system would generate alarms when CO exceeds a nominal range or undergoes dra-
matic change) and use it in a hospital to see whether such a system provides clinicians with
valuable information that is not available otherwise.
Stroke volume variability. Variabilities of CO estimates are different amongst the esti-
mation methods. By removing heart rate out of the equation, we can obtain variability of
stroke volume, which raises a couple of interesting questions. First, which method of ob-
taining stroke volume gives the variability level that closest resembles reality? Second, does
an increase in stroke volume variability of a patient forewarn the onset of certain disease
processes? Is stroke volume variability closely coupled with heart rate variability? Querying
for "heart rate variability" yields 5644 articles on PubMed online. Querying "stroke volume
variability" yields a scant 6 articles, which means there may be new research potential here.
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Appendix A
Notation Summary
Table A.1: Commonly used acronyms ar
description
cardiac output
instantaneous pulsatile flow
P arterial blood pressure
mean arterial pressure
systolic pressure
diastolic pressure
pulse pressure (P. - Pd)
heart rate
beat duration (60/f)
duration of systole
duration of diastole (T - T,)
PVR systemic resistance
arterial capacitance (compliance)
area under P(t) during systole
d symbols
units
L/min
ml/s
mmHg
mmHg
mmHg
mmHg
mmHg
beats per minute
sec
sec
sec
mmHg.s/ml
ml/mmHg
mmHg-s
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symbol
Q, CO
q(t)
P(t), AB
Pm
PS
Pd
Ppf
T
TS
Td
R, SVR,.
C
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Appendix B
Selected Code Descriptions
All MATLAB code may be obtained at http://mimic.mit.edu/svn/jco/trunk/, provided
that you have access permissions.
B.1 wavex.m
WAVEX Arterial blood pressure waveform extractor.
WAVEX(CASEID,INDIR,OUTF) extracts entire ABP waveform of CASEID in the
directory INDIR, then store as MAT-file named OUTF.
In: CASEID (integer) e.g. caseid=3784;
INDIR (string) e.g. indir='01-11-08/m2w03784/';
OUTF (string) e.g. outf='/tmp/p3784';
Out: OUTF.mat Within this MAT-file, there are variables:
abp* --- continuous abp waveform segments
to --- col 1: initial time of each ABP segment
2: # of samples of each ABP segment
source-file --- cell array containing WFDB file name of ABP segs
Usage:
- Make sure wfdb package is installed for linux
- wfdbtools for MATLAB is required
B.2 trendex.m
TRENDEX MIMIC II trend extractor
Y = TRENDEX(CASEID,FNAME,TREND) extracts TREND of CASEID from file FNAME.
In: caseid (integer) e.g. caseid=3784;
fname (string) e.g. fname='trends/01-11-08/004_m2t03784';
trend e.g. trend='CO' or trend='HR' or trend='all';
Out: <lxi> struct
Y.caseid --- caseid
Y.to --- absolute starting time of record (datenum format)
Y.CO --- <kx2> matrix containing time offset (minutes) from
beginning of record and corresponding CO (L/min)
Y... --- examine the struct for more possible trends
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Usage:
- Make sure wfdb package is installed for linux
- wfdb-tools for MATLAB is required
- if 3rd argument is 'all', then all trends of CASEID are obtained
B.3 wabp.m
WABP ABP waveform onset detector.
r = WABP(ABP) obtains the onset time (in samples)
of each beat in the ABP waveform.
In: ABP (125Hz sampled)
Out: Onset sample time
Usage:
- ABP waveform must have units of mmHg
B.4 abpfeature.m
ABPFEATURE ABP waveform feature extractor.
r = ABPFEATURE(ABP,ONSETTIMES) extracts features from ABP waveform such
as systolic pressure, mean pressure, etc.
In: ABP (125Hz sampled), times of onset (in samp
Out: Beat-to-beat ABP features
Col 1: Time of systole [samples]
2: Systolic BP [mmHg]
3: Time of diastole [samples]
4: Diastolic BP [mmHg]
5: Pulse pressure [mmHg]
6: Mean pressure [mmHg]
7: Beat Period [samples]
8: mean.dyneg
9: End of systole time 0.3*sqrt(RR)
10: Area under systole 0.3*sqrt(RR)
11: End of systole time 1st min-slope
12: Area under systole 1st min-slope
Usage:
- OnsetTimes must be obtained using wabp.m
B.5 jSQI.m
les)
method
method
method
method
JSQI ABP waveform signal quality index.
[BEATQ, RI = JSQI(FEATURES, ONSET, ABP) returns a binary signal quality
assessment of each beat in ABP. This algorithm relies on detecting
abnormalities of numeric values in FEATURES and ONSET.
In: FEATURES <mx12> --- features extracted from ABP using abpfeature.m
ONSET <nxl> --- onset times of ABP using wabp.m
ABP <pxl> --- arterial blood pressure waveform (125Hz sampled)
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Out: BEATQ <nxi0> --- SQI of each beat: 0=good, 1=bad
Col 1: logical OR of cols 2 thru 10
2: P not physiologic (<20 or >300 mmHg)
3: MAP not physiologic (<30 or >200 mmHg)
4: HR not physiologic (<20 or >200 bpm)
5: PP not physiologic (<30 mmHg)
6: abnormal Psys (beat-to-beat change > 20 mmHg)
7: abnormal Pdias (beat-to-beat change > 20 mmHg)
8: abnormal period (beat-to-beat change > 1/2 sec)
9: abnormal P(onset) (beat-to-beat change > 20 mmHg)
10: noisy beat (mean of negative dP < -3)
R <lxi> fraction of good beats in ABP
Usage:
- FEATURES must be obtained using abpfeature.m
- ONSET must be obtained using wabp.m
B.6 estimateCO.m
ESTIMATECO Cardiac output estimator.
[CO, TO, TOLD, FEA] = ESTIMATECO(FNAME, ESTID, FILTORDER) is the
main function for estimating cardiac output.
In: FNAME
ESTID
FILTORDER
Out: CO
TO
TOLD
FEA
<1xn>
<lxi>
<lxi>
<kxl>
<kxl>
<mxl>
<kxlI
Usage:
This function is only
done in the following
ESTID 1: est01_MAP
2: est02_WK
3: est03_SA
4: est04-SAwarne
5: estO5_Lilj
6: est06_Herd
7: est07_SAwessC
8: est08-Pulsior
9: est09_LidCO
10: est10_RCdeca3
11: estllmf
--- file where ABP and features are located
--- the CO estimator to use
--- order of running avg LPF to use on output
(enter 0 or 1 for no LPF)
--- estimated CO (uncalibrated)
--- time [minutes] (not evenly sampled!)
--- time [minutes], not sqi filtered
> --- feature matrix
a wrapper. Actual CO estimation computation is
required functions:
- Mean pressure
- Windkessel 1st order LTI RC circuit model
- Systolic area distributed model
r - Warner systolic area with time correction
- Liljestrand PP/(Psys+Pdias) estimator
- Herd estimator
I - Wesseling systolic area with impedance correction
- Pulsion non-linear compliance model
- LidCO root-mean-square model
- RC exponential decay fit
- Wesseling non-linear, time-varying 3-element model
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Appendix C
Test of Statistical Significance
Table C.1 below shows the p-values using the Kolmogorov-Smirnov test (KS test). The
KS test performs pairwise comparisons of error distributions (Figures 5-3, 5-4) between the
CO estimation methods. Table C.2 corresponds the method numbers in Table C.1 with the
actual names.
Table C.1: p-values using the Kolmogorov-Smirnov test.
Method 2 3 4 5 6 7 8 9 10 11 12
1 0.68 0.29 0.07 1.2e-4 0.27 0.20 0.05 0.50 4.7e-15 9.8e-12 6.le-3
2 1 0.22 1.8e-4 0.43 0.96 0.37 0.95 8.8e-15 2.6e-11 1.le-3
3 0.32 5.5e-5 0.46 0.90 0.22 0.98 1.9e-14 4.8e-11 6.3e-4
4 7.6e-8 0.02 0.04 4.5e-3 0.29 4.7e-11 4.4e-8 1.3e-7
5 6.le-3 1.3e-3 8.2e-3 8.2e-5 3.0e-29 2.2e-23 0.02
6 0.88 0.99 0.32 8.4e-17 3.5e-14 0.01
7 0.64 0.85 3.le-16 1.0e-12 3.7e-4
8 0.32 9.9e-19 1.le-14 8.2e-3
9 6.4e-14 8.0e-11 2.0e-5
10 0.55 1.4e-24
11 2.9e-19
Table C.2: Labels for CO estimation methods.
CO estimation method Label
Mean arterial pressure 1
Windkessel 2
Windkessel RC decay 3
Herd 4
Liljestrand nonlinear compliance 5
Systolic area 6
Systolic area with correction 7
Systolic area with corrected impedance 8
Pressure root-mean-square 9
Godje nonlinear compliance 10
Wesseling Modelflow 11
Constant CO 12
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